J Descamps

3.0k total citations · 2 hit papers
59 papers, 2.5k citations indexed

About

J Descamps is a scholar working on Epidemiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, J Descamps has authored 59 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 17 papers in Organic Chemistry and 15 papers in Molecular Biology. Recurrent topics in J Descamps's work include Herpesvirus Infections and Treatments (22 papers), Synthesis and Characterization of Heterocyclic Compounds (13 papers) and Cytomegalovirus and herpesvirus research (7 papers). J Descamps is often cited by papers focused on Herpesvirus Infections and Treatments (22 papers), Synthesis and Characterization of Heterocyclic Compounds (13 papers) and Cytomegalovirus and herpesvirus research (7 papers). J Descamps collaborates with scholars based in Belgium, United Kingdom and United States. J Descamps's co-authors include Erik De Clercq, A. S. JONES, Richard Walker, P. De Somer, Paul F. Torrence, David Shugar, G. VERHELST, P J Barr, Antonı́n Holý and L Missotten and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

J Descamps

59 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex Virus

1980 552 citations Erik De Clercq, J Descamps et al. profile →
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.

1979 404 citations Erik De Clercq, J Descamps et al. profile →

Peers

Countries citing papers authored by J Descamps

Since Specialization

Citations

This map shows the geographic impact of J Descamps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Descamps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Descamps more than expected).

Fields of papers citing papers by J Descamps

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Descamps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Descamps. The network helps show where J Descamps may publish in the future.

Co-authorship network of co-authors of J Descamps

This figure shows the co-authorship network connecting the top 25 collaborators of J Descamps. A scholar is included among the top collaborators of J Descamps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Descamps. J Descamps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In search of acceptable alternatives to the murine histamine sensitisation test (HIST): what is possible and practical? 2016 ·PubMed ·(unknown), Richard Isbrucker, Camille Locht, Juan Arciniega, (unknown), Richard McFarland, (unknown), (unknown), J Descamps, Svein Rune Andersen, Gupta Rk, Kevin Markey, Jean-Michel Chapsal, Katie Lidster, (unknown), David Allen	6
2	The consistency approach for quality control of vaccines – A strategy to improve quality control and implement 3Rs 2011 ·Biologicals ·Fabrizio De Mattia, Jean-Michel Chapsal, J Descamps, Marlies Halder, (unknown), (unknown), (unknown), (unknown), Keith Redhead, (unknown), Coenraad Hendriksen	64
3	Non-animal replacement methods for human vaccine potency testing: state of the science and future directions 2011 ·PubMed ·Richard McFarland, Daniela Verthelyi, Warren Casey, Juan Arciniega, Richard Isbrucker, (unknown), Theresa M. Finn, J Descamps, Yoshinobu Horiuchi, Dorothea Sesardic, Paul Stickings, (unknown), Elizabeth A. Lipscomb, David Allen	27
4	The consistency approach for the quality control of vaccines 2007 ·Biologicals ·Coenraad Hendriksen, Juan Arciniega, (unknown), Michel Chevalier, (unknown), J Descamps, (unknown), (unknown), Marlies Halder, (unknown), A. Maes, Keith Redhead, (unknown), (unknown), (unknown)	51
5	Evaluation of an atrophic rhinitis vaccine under controlled conditions 1992 ·Veterinary Record ·(unknown), (unknown), (unknown), A. Wiseman, J Descamps	2
6	Prevalence ofLeptospira interrogansserovarhardjoantibodies in milk in Belgian dairy herds 1991 ·Veterinary Quarterly ·Peter Dom, Freddy Haesebrouck, (unknown), J Descamps, (unknown)	7
7	Influence of (E)-5-(2-Bromovinyl)-2′-deoxyuridine on corneal epithelium healing 1982 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·P. C. Maudgal, (unknown), Erik De Clercq, J Descamps, L Missotten, (unknown)	3
8	Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines. 1982 ·Molecular Pharmacology ·Erik De Clercq, Jan Balzarini, J Descamps, Guay‐Fen Huang, Paul F. Torrence, Donald E. Bergstrom, (unknown), Pawel J. Serafinowski, G. VERHELST, Richard Walker	24
9	Mode of action of acyclovir triphosphate on herpesviral and cellular DNA polymerases 1982 ·Antiviral Research ·H.S. Allaudeen, J Descamps, Raj K. Sehgal	16
10	Effects of E-5-(2-Bromovinyl)-2'-Deoxyuridine and Other Selective Anti-Herpes Compounds on the Induction of Retrovirus Particles in Mouse BALB/3T3 Cells 1981 ·Molecular Pharmacology ·Erik De Clercq, Hubertine Heremans, J Descamps, G. VERHELST, Marc De Ley, Alfons Billiau	17
11	Selective anti-herpes activity of 5-(2-halogenovinyl)-2'-deoxyuridines and 2'-deoxycytidines 1981 ·Lirias (KU Leuven) ·Erik De Clercq, J Descamps, P. C. Maudgal, (unknown), (unknown), G. VERHELST, A. S. JONES, Richard Walker, Roger Busson, H. Vanderhaeghe, P. De Somer	9
12	Specific phosphorylation of E-5-(2-iodovinyl)-2'-deoxyuridine by herpes simplex virus-infected cells. 1981 ·Journal of Biological Chemistry ·J Descamps, Erik De Clercq	64
13	Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster. 1980 ·BMJ ·Erik De Clercq, H. Degreef, J. Wildiers, (unknown), A Drochmans, J Descamps, P. De Somer	108
14	Comparative evaluation of BVDU ((E)-5-(2-bromovinyl)-2'-deoxyuridine)and IDU (5-iodo-2'-deoxyuridine) in the treatment of experimental herpes simplex keratitis in rabbits 1979 ·P. C. Maudgal, Erik De Clercq, J Descamps, L Missotten	19
15	Antiviral activity of 5-methylthiomethyl-2′deoxyuridine and other 5-substituted 2′-deoxyuridines 1979 ·Biochemical Pharmacology ·Erik De Clercq, J Descamps, Charles L. Schmidt, Mathias P. Mertes	20
16	5-Substituted uracil arabinonucleosides as potential antiviral agents 1979 ·Journal of Medicinal Chemistry ·Paul F. Torrence, (unknown), Michael W. Edwards, Bharat Bhooshan, J Descamps, Erik De Clercq	12
17	5-Nitro-2'-deoxyuridine and 5-Nitro-2'-deoxyuridine 5'-Monophosphate: Antiviral Activity and Inhibition of Thymidylate Synthetase in Vivo 1978 ·Molecular Pharmacology ·Erik De Clercq, J Descamps, (unknown), Paul F. Torrence	46
18	ChemInform Abstract: 5‐O‐ALKYLATED DERIVATIVES OF 5‐HYDROXY‐2′‐DEOXYURIDINE AS POTENTIAL ANTIVIRAL AGENTS. ANTI‐HERPES ACTIVITY OF 5‐PROPYNYLOXY‐2′‐DEOXYURIDINE 1978 ·Chemischer Informationsdienst ·Paul F. Torrence, John Spencer, Albert M. Bobst, J Descamps, Erik De Clercq	2
19	The synthesis and properties of some antiviral nucleosides 1978 ·Nucleic Acids Research ·Roland Walker, P J Barr, Erik De Clercq, J Descamps, A. S. JONES, Pawel J. Serafinowski	30
20	5-Propyl-2'-deoxyuridine: a specific anti-herpes agent 1978 ·Antimicrobial Agents and Chemotherapy ·Erik De Clercq, J Descamps, David Shugar	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact